Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: A multicenter study (Q68362989)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3370931%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3370931%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: A multicenter study (English)

1 reference

https://api.crossref.org/works/10.1016/0732-8893(88)90060-0

2 January 2023

1

P. C. Fuchs

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3370931

2 January 2023

6

E. H. Gerlach

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3370931

2 January 2023

author name string

R. N. Jones

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3370931

2 January 2023

A. L. Barry

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3370931

2 January 2023

S. D. Allen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3370931

2 January 2023

K. E. Aldridge

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3370931

2 January 2023

H. M. Sommers

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3370931

2 January 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3370931

2 January 2023

publication date

1 January 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3370931%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

https://api.elsevier.com/content/article/PII:0732889388900600?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0732-8893(88)90060-0

https://api.elsevier.com/content/article/PII:0732889388900600?httpAccept=text/plain

2 January 2023

1 reference

https://api.crossref.org/works/10.1016/0732-8893(88)90060-0

Diagnostic Microbiology and Infectious Disease

2 January 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3370931%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3370931%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3370931%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

47-50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3370931%20AND%20SRC:MED&resulttype=core&format=json

In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers

23 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0732-8893(88)90060-0

In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.

2 January 2023

3

1 reference

https://api.crossref.org/works/10.1016/0732-8893(88)90060-0

Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo

2 January 2023

4

1 reference

https://api.crossref.org/works/10.1016/0732-8893(88)90060-0

In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.

2 January 2023

5

1 reference

https://api.crossref.org/works/10.1016/0732-8893(88)90060-0

Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other β-lactams

2 January 2023

6

1 reference

https://api.crossref.org/works/10.1016/0732-8893(88)90060-0

Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production

2 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/0732-8893(88)90060-0

The activity of ticarcillin in combination with clavulanic acid against Bacteroides species: an in-vitro comparison with other antibiotics

2 January 2023

8

1 reference

https://api.crossref.org/works/10.1016/0732-8893(88)90060-0

In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates

2 January 2023

9

1 reference

https://api.crossref.org/works/10.1016/0732-8893(88)90060-0

Antibacterial activity of ticarcillin in the presence of clavulanate potassium

2 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/0732-8893(88)90060-0

2 January 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3370931%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference